Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
6.89
-0.09 (-1.29%)
Sep 20, 2024, 4:00 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $11.63 million as of September 20, 2024. Its market cap has decreased by -51.94% in one year.
Market Cap
11.63M
Enterprise Value
4.55M
1-Year Change
-51.94%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since November 20, 2015, Purple Biotech's market cap has increased from $11.20M to $11.63M, an increase of 3.84%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2024 | 9.50M | -38.71% |
| Dec 29, 2023 | 15.50M | -36.99% |
| Dec 30, 2022 | 24.60M | -63.77% |
| Dec 31, 2021 | 67.90M | 805.33% |
| Dec 31, 2020 | 7.50M | -40.00% |
| Dec 31, 2019 | 12.50M | 68.92% |
| Dec 31, 2018 | 7.40M | -57.71% |
| Dec 29, 2017 | 17.50M | 44.63% |
| Dec 30, 2016 | 12.10M | 9.01% |
| Dec 31, 2015 | 11.10M | -0.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 12.79M |
| QT Imaging Holdings | 12.69M |
| COSCIENS Biopharma | 12.61M |
| RedHill Biopharma | 12.49M |
| STRATA Skin Sciences | 12.47M |
| Tenax Therapeutics | 12.31M |
| Sensei Biotherapeutics | 12.22M |
| Aptorum Group | 12.15M |